Skip to content

A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds

A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05106751
Enrollment
104
Registered
2021-11-04
Start date
2021-10-21
Completion date
2023-04-03
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Correction of Nasolabial Folds

Brief summary

A Study to Evaluate the Performance and Safety of YVOIRE Classic plus on NLF.

Detailed description

This is a Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Study to Evaluate the Performance and Safety of YVOIRE Classic plus Versus Comparator for Temporary Correction of Nasolabial Folds.

Interventions

DEVICEHyaluronic acid dermal filler

Hyaluronic acid dermal filler used for facial volume or wrinkle correction

Sponsors

LG Chem
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female 21 years or above age. * 2 or 3 of the 5-point (0-4) NLFRS (Nasolabial Fold Rating Scale). * Agree to use proper contraception as guided in the protocol. * Signed for Informed Consent.

Exclusion criteria

* have received permanent facial implants anywhere in the face or neck or planning during the investigation. * have undergone facial plastic surgery of the lower face and nasolabial region within 12 weeks * have undergone semi-permanent filler in lower face * have undergone temporary dermal filler treatment in the lower two-thirds of face within 12 months * Have undergone facial tissue augmentation or facial treatment with fat or botulinum injections in the lower two-thirds of face * Have undergone mesotherapy or cosmetic procedures in face or neck within 6 months * have used any over-the-counter anti-wrinkle products or prescription anti-wrinkle medicines for the nasolabial folds within 28 days

Design outcomes

Primary

MeasureTime frameDescription
Mean change on the Nasolabial Fold Rating Scale (NLFRS) from baseline to Week24.24 weeks from baselineTo evaluate the performance of YVOIRE Classic plus on Nasolabial Fold 24 weeks after treatment, the mean change from baseline to 24 weeks will be measured using 5-point Nasolabial Fold Rating Scale (NLFRS). NLFRS Grades are 0 (None/Minimal), 1 (Mild), 2 (Moderate), 3 (Severe), and 4 (Extreme).
Responder rate calculated using Nasolabial Fold Rating Scale (NLFRS) for Nasolabial fold at Week 24.24 weeks from baselineTo evaluate the performance of YVOIRE Classic plus on Nasolabial fold 24 weeks after treatment, the responder rate defined as ≥ 1-point improvement on the 5-point Nasolabial Fold Rating Scale (NLFRS) from baseline to 24 weeks will be calculated.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026